Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2000-6-29
pubmed:abstractText
Productive poliovirus infection of HeLa cells leads to the canonical cytopathic effect (CPE), whereas certain types of abortive infection result in apoptosis. To define the time course of commitment to the different types of poliovirus-induced death, inhibitors of viral replication (guanidine HCl) or translation (cycloheximide) were added at different times postinfection (p.i.). Early in the infection (during the first approximately 2 h p.i.), predominantly proapoptotic viral function was expressed, rendering the cells committed to apoptosis, which developed several hours after viral expression was arrested. In the middle of infection, concomitantly with the onset of fast generation of viral progeny, the implementation of the viral apoptotic program was abruptly interrupted. In particular, activation of an Asp-Glu-Val-Asp (DEVD)-specific caspase(s) occurring in the apoptosis-committed cells was prevented by the ongoing productive infection. Simultaneously, the cells retaining normal or nearly normal morphology became committed to CPE, which eventually developed regardless of whether or not further viral expression was allowed to proceed. The implementation of the poliovirus-induced apoptotic program was suppressed in HeLa cells overexpressing the Bcl-2 protein, indicating that the fate of poliovirus-infected cells depends on the balance of host and viral pro- and antiapoptotic factors.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-10049827, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-10200555, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-10364359, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-1313898, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-14319710, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-2154600, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-6243433, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-6297149, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-6316654, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-7529330, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-7793329, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-8009827, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-8189504, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-8197207, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-8441470, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-8627707, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-8764043, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-8794327, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-8970994, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-8978458, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-8995685, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-9032342, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-9032397, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-9113200, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-9123847, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-9188634, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-9218414, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-9223486, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-9343360, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-9371552, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-9482724, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-9525664, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-9696873, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-9765399, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-9847376, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-9878613, http://linkedlifedata.com/resource/pubmed/commentcorrection/10823859-9988219
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0022-538X
pubmed:author
pubmed:issnType
Print
pubmed:volume
74
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5534-41
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
Competing death programs in poliovirus-infected cells: commitment switch in the middle of the infectious cycle.
pubmed:affiliation
M. P. Chumakov Institute of Poliomyelitis and Viral Encephalitides, Russian Academy of Medical Sciences, Moscow Region 142782, Russia. viago@ipive.genebee.msu.su
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't